Explore Our Library of Biomanufacturing Resources & Technical Data

Application Notes

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

Expansion of Adherent HEK293T Cells in Flasks in Chemically Defined Cell Culture Media

ITS-Animal-Free™ Supplementation for iPSC Expansion and Pluripotency: A Platform Approach for Serum-Free Cell Expansion

Lentivirus Production Protocol in Serum-Free Conditions – How To Improve Transfection Efficiency and Titer Yield

OptiVERO – Virus Production Using VERO Cells in Flasks without Serum in Chemically Defined Cell Culture Media Application Note

OptiVERO – Virus Production Using VERO Cells with Microcarriers Without Serum in Chemically Defined Cell Culture Media

Safe, Consistent Iron Delivery in Serum-Free Systems with Optiferrin® Recombinant Transferrin

Thiol by Combat: Enhanced Covalent Conjugation with Recombinant Albumin Compared to Human Plasma-Derived Albumin

Blog

Albumin in Drug Delivery: Cancer’s Unexpected Achilles’ Heel

Cryopreservation Just Got Better with Optibumin® 25

Evolving Challenges in Closed-System Biomanufacturing

How Regulatory Bodies Are Driving the Shift to Animal-Origin-Free Solutions in Cell Therapy and Vaccine Development

Innovative Solutions in Closed-System Biomanufacturing: Exploring the Tools and Technologies Driving Sterility and Efficiency

Optibumin vs Traditional Albumin: Comparing Performance in Cell Wash Applications

Safety and Contamination Risks: The Testing Burden and Persistent Threats

SARS-CoV2 and Influenza – Double Threat

Scaling Innovation: How DiscGenics and InVitria are Leading the Future of Cell Therapy

Solving the Vaccine Supply Challenge

Variability and Failed Lots: The Hidden Quality Control Challenge of Serum & Serum-Derived Products

Why Do Some Biologics Cross the Finish Line—While Others Crash and Burn?

Catalog

InVitria Product Catalog – 2025

Data Sheets

Cellastim S – Data Sheet

Exbumin – Data Sheet

ITS Animal-Free – Data Sheet

ITSE Animal-Free – Data Sheet

ITSE+A Animal-Free – Data Sheet

Lacromin – Data Sheet

Lysobac – Data Sheet

Optibumin 20 – Data Sheet

Optibumin 25 – Data Sheet

Optiferrin – Data Sheet

Journal Articles (DOI Links)

Formulation and Production of a Blood-free and Chemically Defined Virus Production Media for VERO Cells

Posters

Addressing Vaccine Stability And Cold Chain Challenges With Recombinant Human Serum Albumin To Enable Global Administration

Advancing Vaccine Excellence

Formulation of a Blood-Free and Chemically Defined Virus Production Media for VERO Cells Poster

Product Brochures

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

SDS

Exbumin – Safety Data Sheet

ITSE AF – Safety Data Sheet

Use Guidelines

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Lacromin – Guidelines for Use

Optibumin 20 – Guidelines for Use

Optiferrin – Guidelines for Use

OptiVERO – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

Why Cell Quality Erodes During Downstream Processing — and How to Prevent It | Webinar

White Papers

Cellastim S – Recombinant Human Serum Albumin in the Generation of Functional Cardiomyocytes from Pluripotent Stem Cells

Emergence of Blood-Free Recombinant Human Albumin

Optimizing the Performance of LNP and Liposome Therapeutics with Blood-Free Recombinant Albumin

VERO Expansion in the iCellis® Bioreactor with Chemically Defined and Blood Free Virus Production Media